Skip Navigation


International Immunology Advance Access originally published online on March 30, 2006
International Immunology 2006 18(5):785-795; doi:10.1093/intimm/dxl015
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/5/785    most recent
dxl015v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dueñas, A. I
Right arrow Articles by García-Rodríguez, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dueñas, A. I
Right arrow Articles by García-Rodríguez, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2006. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS

Ana I Dueñas1, Mónica Aceves1, Antonio Orduña2, Ramón Díaz3, Mariano Sánchez Crespo1 and Carmen García-Rodríguez1

1 Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, Valladolid, Spain
2 Unidad de Investigación, Hospital Clínico Universitario, Valladolid, Spain
3 Departamento de Microbiología, Universidad de Navarra, Pamplona, Spain

Correspondence to: C. García-Rodríguez; E-mail: cgarcia{at}ibgm.uva.es

Francisella tularensis is a virulent Gram-negative intracellular pathogen. To address the signaling routes involved in the response of host cells to LPS from F. tularensis live vaccine strain (LVS), experiments were performed in transiently transfected 293 cells. Induction of {kappa}B-driven transcriptional activity by 2.5 µg ml–1 F. tularensis LPS isolated by phenol–water and ether–water extraction, was observed in cells transfected with Toll-like receptor (TLR) 4 and MD-2, although CD14 was required for optimal induction. Conversely, TLR2, TLR2/TLR1 or TLR2/TLR6 transfected cells did not show {kappa}B-driven transcriptional activity in the presence of F. tularensis LPS. In human monocytic cells, F. tularensis LPS activated extracellular signal-regulated kinases and the production of pro-inflammatory proteins. Concentrations of 5–10 µg ml–1 F. tularensis LPS elicited a similar pattern of mRNA and protein induction than 0.1 µg ml–1 E. coli LPS, including the expression of CXC chemokines (IL-8, Gro and IFN-{gamma}-inducible protein-10); CC chemokines (monocyte chemoattractant protein-1 and -2, macrophage-derived chemoattractant, macrophage inflammatory protein-1{alpha} and -1ß and RANTES (regulated upon activation, normal T cell expressed and secreted) and pro-inflammatory cytokines (IL-6 and tumor necrosis factor {alpha}). Altogether, these data indicate that LPS from F. tularensis LVS signals via TLR4 at higher concentrations than those required for E. coli LPS, which may explain the inflammatory reaction and the low endotoxic response associated to vaccination with LVS in humans.

Keywords: bacterial infection, chemokines, LPS, mitogen-activated protein kinase, transcription factors

Transmitting editor: Giorgio Trinchieri


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Lembo, M. Pelletier, R. Iyer, M. Timko, J. C. Dudda, T. E. West, C. B. Wilson, A. M. Hajjar, and S. J. Skerrett
Administration of a Synthetic TLR4 Agonist Protects Mice from Pneumonic Tularemia
J. Immunol., June 1, 2008; 180(11): 7574 - 7581.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Gentry, J. Taormina, R. B. Pyles, L. Yeager, M. Kirtley, V. L. Popov, G. Klimpel, and T. Eaves-Pyles
Role of Primary Human Alveolar Epithelial Cells in Host Defense against Francisella tularensis Infection
Infect. Immun., August 1, 2007; 75(8): 3969 - 3978.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. Gallagher, E. Ramage, M. A. Jacobs, R. Kaul, M. Brittnacher, and C. Manoil
A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate
PNAS, January 16, 2007; 104(3): 1009 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. M. Hajjar, M. D. Harvey, S. A. Shaffer, D. R. Goodlett, A. Sjostedt, H. Edebro, M. Forsman, M. Bystrom, M. Pelletier, C. B. Wilson, et al.
Lack of In Vitro and In Vivo Recognition of Francisella tularensis Subspecies Lipopolysaccharide by Toll-Like Receptors
Infect. Immun., December 1, 2006; 74(12): 6730 - 6738.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.